These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6253069)

  • 1. Haemodynamic effects of angiotensin converting enzyme inhibition after cardiopulmonary bypass in dogs.
    Taylor KM; Casals JG; Mittra SM; Brannan JJ; Morton JJ
    Cardiovasc Res; 1980 Apr; 14(4):199-205. PubMed ID: 6253069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass.
    Taylor KM; Bain WH; Russell M; Brannan JJ; Morton IJ
    Thorax; 1979 Oct; 34(5):594-8. PubMed ID: 515979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II in the development of peripheral vasoconstriction during cardiopulmonary bypass.
    Taylor KM; Brannan JJ; Bain WH; Caves PK; Morton IJ
    Cardiovasc Res; 1979 May; 13(5):269-73. PubMed ID: 476747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
    Manson NH; Hess ML
    Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme.
    Morton JJ; Tree M; Casals-Stenzel J
    Clin Sci (Lond); 1980 Jun; 58(6):445-50. PubMed ID: 6253115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
    Miura K; Abe Y; Yamamoto K
    J Pharmacol Exp Ther; 1982 Jul; 222(1):246-50. PubMed ID: 6177851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass.
    Oh YJ; Lee JH; Nam SB; Shim JK; Song JH; Kwak YL
    Br J Anaesth; 2006 Dec; 97(6):792-8. PubMed ID: 17032660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
    Ohara N; Yokota S; Konishi C; Shukunobe K; Ono H
    J Pharmacobiodyn; 1991 Dec; 14(12):655-62. PubMed ID: 1812274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
    Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of arginine vasopressin and angiotensin II in cardiovascular responses to combined acute hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Godine RL; Rose KY; Anderson RJ; Carey RM
    J Clin Invest; 1984 Aug; 74(2):321-31. PubMed ID: 6547729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II provokes cesium-induced ventricular tachyarrhythmias.
    Gondo N; Kumagai K; Nakashima H; Saku K
    Cardiovasc Res; 2001 Feb; 49(2):381-90. PubMed ID: 11164848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients.
    Boldt J; Schindler E; Härter K; Görlach G; Hempelmann G
    Anesth Analg; 1995 Mar; 80(3):480-5. PubMed ID: 7864411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure.
    Flapan AD; Shaw TR; Edwards CR; Rademaker M; Davies E; Williams BC
    Eur J Clin Pharmacol; 1992; 43(1):1-5. PubMed ID: 1505601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine-vasopressin.
    Feddersen K; Aurell M; Delin K; Häggendal J; Arén C; Rådegran K
    Acta Anaesthesiol Scand; 1985 Feb; 29(2):224-30. PubMed ID: 3883684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.